209 related articles for article (PubMed ID: 27255234)
1. Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats.
Sun J; Sun B; Wang W; Han X; Liu H; Du J; Feng W; Liu B; Amizuka N; Li M
J Mol Histol; 2016 Aug; 47(4):389-99. PubMed ID: 27255234
[TBL] [Abstract][Full Text] [Related]
2. ED-71 Improves Bone Mass in Ovariectomized Rats by Inhibiting Osteoclastogenesis Through EphrinB2-EphB4-RANKL/OPG Axis.
Wang K; Kou Y; Rong X; Wei L; Li J; Liu H; Li M; Song H
Drug Des Devel Ther; 2024; 18():1515-1528. PubMed ID: 38716369
[TBL] [Abstract][Full Text] [Related]
3. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
4. The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo.
Ge YW; Feng K; Liu XL; Chen HF; Sun ZY; Wang CF; Liu ZQ; Wang HW; Zhang JW; Yu DG; Mao YQ
Oxid Med Cell Longev; 2020; 2020():1404915. PubMed ID: 32587656
[TBL] [Abstract][Full Text] [Related]
5. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
6. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
Tian QX; Huang GY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):418-22. PubMed ID: 15379268
[TBL] [Abstract][Full Text] [Related]
7. ED-71 inhibited osteoclastogenesis by enhancing EphrinB2-EphB4 signaling between osteoclasts and osteoblasts in osteoporosis.
Zhang Y; Kou Y; Yang P; Rong X; Tang R; Liu H; Li M
Cell Signal; 2022 Aug; 96():110376. PubMed ID: 35690294
[TBL] [Abstract][Full Text] [Related]
8. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
9. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
10. Boning up on ephrin signaling.
Mundy GR; Elefteriou F
Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
[TBL] [Abstract][Full Text] [Related]
11. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
[TBL] [Abstract][Full Text] [Related]
12. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
13. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone affects the OPG/RANKL/RANK system and increase osteoclastogenesis.
Xu F; Dong Y; Huang X; Chen P; Guo F; Chen A; Huang S
Mol Med Rep; 2016 Sep; 14(3):2289-96. PubMed ID: 27430581
[TBL] [Abstract][Full Text] [Related]
15. Sodium fluoride induces hypercalcemia resulting from the upregulation of both osteoblastic and osteoclastic activities in goldfish, Carassius auratus.
Sato M; Hanmoto T; Yachiguchi K; Tabuchi Y; Kondo T; Endo M; Kitani Y; Sekiguchi T; Urata M; Hai TN; Srivastav AK; Mishima H; Hattori A; Suzuki N
Comp Biochem Physiol C Toxicol Pharmacol; 2016 Nov; 189():54-60. PubMed ID: 27475026
[TBL] [Abstract][Full Text] [Related]
16. The importance of estrogen for bone protection in experimental hyperthyroidism in human osteoblasts.
Olímpio RMC; Moretto FCF; De Sibio MT; de Oliveira M; Mathias LS; Gonçalves BM; Deprá IC; Tilli HP; Rodrigues BM; Saraiva PP; Maria DA; Nogueira CR
Life Sci; 2019 Aug; 231():116556. PubMed ID: 31194990
[TBL] [Abstract][Full Text] [Related]
17. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
18. High extracellular Ca2+ alone stimulates osteoclast formation but inhibits in the presence of other osteoclastogenic factors.
Shin MM; Kim YH; Kim SN; Kim GS; Baek JH
Exp Mol Med; 2003 Jun; 35(3):167-74. PubMed ID: 12858015
[TBL] [Abstract][Full Text] [Related]
19. Environmental level of cadmium exposure stimulates osteoclasts formation in male rats.
Chen X; Wang G; Li X; Gan C; Zhu G; Jin T; Wang Z
Food Chem Toxicol; 2013 Oct; 60():530-5. PubMed ID: 23954550
[TBL] [Abstract][Full Text] [Related]
20. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
